Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Código QR

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-22614-1.

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, Li Guo, Ruixuan Guo, Ting Chen, Jiaxin Hu, Zichun Xiang, Zhixia Mu, Xing Chen, Jieyong Chen, Keping Hu, Qi Jin, Jianwei Wang, Zhaohui Qian
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/5eac91162bcc49d5a1959a0f094356f1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Xiuyuan Ou, et al.
Publicado: (2020)

Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2
por: Antoni G. Wrobel, et al.
Publicado: (2021)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Jing-Hui Tian, et al.
Publicado: (2021)

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
por: Yuan Yuan, et al.
Publicado: (2017)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu T, et al.
Publicado: (2021)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Xiaobo Lei, et al.
Publicado: (2020)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors
por: Paul G. Ayoub, et al.
Publicado: (2021)

An Update on the Relationship of SARS-CoV-2 and Male Reproduction
por: Juncen Guo, et al.
Publicado: (2021)

Testing for SARS-CoV-2
por: Popadić Dušan
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Josef Finsterer
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
por: Antonio Muruato, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Antonio Muruato, et al.
Publicado: (2021)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Shuyuan Zhang, et al.
Publicado: (2021)

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
por: Xiaoyi Fan, et al.
Publicado: (2020)

Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus
por: Leštarević Snežana, et al.
Publicado: (2021)

The architecture of the SARS-CoV-2 RNA genome inside virion
por: Changchang Cao, et al.
Publicado: (2021)

Mechanisms of Immunothrombosis by SARS-CoV-2
por: María Teresa Hernández-Huerta, et al.
Publicado: (2021)

Hotspot Mutations in SARS-CoV-2
por: Indrajit Saha, et al.
Publicado: (2021)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
por: Les Jones, et al.
Publicado: (2021)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Hagit Achdout, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP
por: José Zúñiga, et al.
Publicado: (2021)

Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
por: Michael Laue, et al.
Publicado: (2021)

Immunoreactive peptide maps of SARS-CoV-2
por: Nischay Mishra, et al.
Publicado: (2021)

Defensive Properties of Mucin Glycoproteins during Respiratory Infections—Relevance for SARS-CoV-2
por: Maitrayee Chatterjee, et al.
Publicado: (2020)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Yijun Liu, et al.
Publicado: (2021)

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
por: Yunkai Zhu, et al.
Publicado: (2021)

Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens
por: Fabian Z. X. Lean, et al.
Publicado: (2020)

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
por: Chia-En Lien, et al.
Publicado: (2021)

SARS-CoV-2: a new threat
por: López Rodríguez Cristina A., et al.
Publicado: (2020)

SARS-CoV-2: una nueva amenaza
por: López Rodríguez Cristina A., et al.
Publicado: (2020)

Bell’s Palsy Caused by SARS-CoV-2
por: Maythem Al-Kaisy, et al.
Publicado: (2021)

SARS-CoV-2 and Public Transport in Italy
por: Giuseppina Caggiano, et al.
Publicado: (2021)

Glomerulonephritis associated with SARS-CoV-2 infection
por: Mohsen Akhavan Sepahi, et al.
Publicado: (2021)

Transplacental transmission of SARS-CoV-2 infection
por: Alexandre J. Vivanti, et al.
Publicado: (2020)

Racing for a SARS‐CoV‐2 vaccine
por: Özlem Türeci, et al.
Publicado: (2021)

Genomic diversity of SARS-CoV-2 in Malaysia
por: Noorliza Mohamad Noordin, et al.
Publicado: (2021)

Epidemiological and Immunological Features of Obesity and SARS-CoV-2
por: Eric J. Nilles, et al.
Publicado: (2021)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
por: Donal T. Skelly, et al.
Publicado: (2021)